| Primary Diagnosis | Year | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | |
| Total | 874 | 1,029 | 1,254 | 1,421 | 1,482 | 1,653 | 2,057 | 1,788 | 1,205 | 927 |
| Emphysema/COPD | 229 | 287 | 352 | 363 | 380 | 385 | 500 | 427 | 269 | 220 |
| Cystic Fibrosis | 110 | 126 | 160 | 190 | 184 | 196 | 295 | 262 | 183 | 145 |
| Idiopathic Pulmonary Fibrosis | 106 | 121 | 154 | 201 | 198 | 259 | 338 | 289 | 205 | 148 |
| Alpha-1-Antitrypsin Deficiency | 48 | 52 | 70 | 69 | 85 | 101 | 105 | 91 | 62 | 51 |
| Idiopathic Pulmonary Arterial Hypertension | 164 | 190 | 215 | 261 | 263 | 301 | 321 | 274 | 163 | 126 |
| Retransplant/Graft Failure | 26 | 35 | 40 | 35 | 41 | 32 | 40 | 36 | 27 | 18 |
| Congenital Disease | 45 | 41 | 41 | 48 | 55 | 60 | 58 | 50 | 30 | 17 |
| Other | 146 | 177 | 222 | 254 | 276 | 319 | 400 | 359 | 266 | 202 |
| Total (%) | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Emphysema/COPD | 26.2% | 27.9% | 28.1% | 25.5% | 25.6% | 23.3% | 24.3% | 23.9% | 22.3% | 23.7% |
| Cystic Fibrosis | 12.6% | 12.2% | 12.8% | 13.4% | 12.4% | 11.9% | 14.3% | 14.7% | 15.2% | 15.6% |
| Idiopathic Pulmonary Fibrosis | 12.1% | 11.8% | 12.3% | 14.1% | 13.4% | 15.7% | 16.4% | 16.2% | 17.0% | 16.0% |
| Alpha-1-Antitrypsin Deficiency | 5.5% | 5.1% | 5.6% | 4.9% | 5.7% | 6.1% | 5.1% | 5.1% | 5.1% | 5.5% |
| Idiopathic Pulmonary Arterial Hypertension | 18.8% | 18.5% | 17.1% | 18.4% | 17.7% | 18.2% | 15.6% | 15.3% | 13.5% | 13.6% |
| Retransplant/Graft Failure | 3.0% | 3.4% | 3.2% | 2.5% | 2.8% | 1.9% | 1.9% | 2.0% | 2.2% | 1.9% |
| Congenital Disease | 5.1% | 4.0% | 3.3% | 3.4% | 3.7% | 3.6% | 2.8% | 2.8% | 2.5% | 1.8% |
| Other | 16.7% | 17.2% | 17.7% | 17.9% | 18.6% | 19.3% | 19.4% | 20.1% | 22.1% | 21.8% |